[Retracted] The Effectiveness and Safety of Hormonal Combinations of Antiepileptic Drugs in the Treatment of Epileptic Electrical Continuity in Children during Sleep: A Meta-Analysis

Table 1

Characteristics of individual studies included in the meta-analysis.

Study (year)	Age (E/C)	Sample (E/C)	Dosage and usage(E/C)	Outcomes
Feng 2019 [14]	7.81 ± 2.35/7.83 ± 2.36	43/43	Methylprednisolone + prednisone + Valproic acid/Valproic acid	①②③④
Chen 2017 [15]	4.0∼13/4.4∼14	12/15	Methylprednisolone + prednisone + AED/AED ()	③
Wang 2015 [16]	8.4 ± 2.8/7.6 ± 2.7	32/32	Methylprednisolone + prednisone + AED/AED(not described in detail)	①②③
Liu 2014 [17]	6.3 ± 2.3/6.1 ± 2.6	28/28	Methylprednisolone + prednisone + AED/AED(not described in detail)	②③④
Guo 2016 [18]	7.24 ± 1.76/6.82 ± 2.03	12/12	Methylprednisolone + prednisone + AED/AED(not described in detail)	②③
Cai 2020 [19]	8.18 ± 1.37/8.34 ± 1.34	43/43	Methylprednisolone + prednisone + Levetiracetam/Levetiracetam	①②③④
Lin; 2017 [20]	8.7 ± 2.4/8.9 ± 2.5	35/34	Methylprednisolone + prednisone + Oxcarbazepine/Oxcarbazepine	①②③④
Zhang 2020 [21]	7.56 ± 2.49/7.48 ± 2.43	36/36	Methylprednisolone + prednisone + Topiramate, valproic acid/Topiramate, valproic acid	①②③④
Chen 2021 [22]	6.02 ± 0.64	30/30	Methylprednisolone sodium Succinate + prednisone + AED/AED(not described in detail)	②③
Zhang 2014 [23]	4∼14	16/15	Methylprednisolone + prednisone + Sodium valproate/Sodium valproate	③④
Fu 2020 [24]	7.00 ± 0.82/7.02 ± 0.75	37/37	Methylprednisolone sodium Succinate + prednisone + Sodium valproate/Sodium valproate	①③④
Zhao 2019 [25]	7.8 ± 1.3/7.9 ± 1.2	45/44	Methylprednisolone sodium Succinate + prednisone + Sodium valproate/Sodium valproate	①③④
Huang 2016 [26]	8.9 ± 2.7/9.1 ± 2.5	34/33	Methylprednisolone + prednisone + Oxcarbazepine/Oxcarbazepine	③④

①Wechsler Intelligence Scale for Children; ②The effective rate (ER); ③EEG discharges; ④Adverse effects rate (AER).